Twenty-four-hour blood pressure-lowering effect of a Sodium-glucose cotransporter 2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension: results from the randomized, placebo-controlled SACRA study
Research indicates that weight reduction is sustained as therapy continues, with no weight recovery, suggesting significant alterations in energy balance rather than transient effects (Christoffersen et al
Three amino acidsglutamate, glycine, and cysteinecombine to form glutathione
The quality of the specific formulation matters
The increased prevalence indicates the need for novel therapeutic strategies and supportive care to manage the symptoms of these neurodegenerative diseases and to improve the quality of life for the affected individuals
Compounding is an important alternative that can help resolve shortages and provide alternatives for patients who need personalized dosages, ingredients, or who need the removal of allergens